HEALTH OF WOMAN. 2016.3(109):48–51; doi 10.15574/HW.2016.109.48 
 

Prevention of obstetric and perinatal complications in pregnant women with viral Epstein–Barr infection 
 

Pekar A. Yu., Mitsoda R. M.

SHEE «Uzhgorod national University» 
 

One of the most common infections in the world is an infection caused by the Epstein-Barr virus (EBV) infection. The urgency of the problem caused by the wide circulation of this virus among the population, a variety of clinical forms, high risk of carcinogenesis, the influence on the gestation process and the lack of tactics for pregnant women with EBV infection.

The objective: to evaluate the effectiveness of the proposed treatment and preventive measures for the prevention of obstetric and perinatal complications in pregnant women with EBV infection.

Patients and methods. We observed 106 pregnant women, 71 of them pregnant with reactivation of EBV infection were divided into two groups: I group – 31 pregnant women who received conventional treatment and preventive measures; II group – 40 pregnant women receiving treatment and preventive measures proposed by us. The control group consisted of 35 pregnant women with latent EBV infection, without obstetric and somatic disease who become pregnant on their own and were delivery was vaginally.

Results. It was found that in pregnant women with reactivation of EBV infection during treatment with interferon alfa-2b human recombinant and thymus extract cattle on the proposed scheme, there was a significant decrease in the incidence of obstetric and perinatal pathology.

Conclusion. The results indicate that the effectiveness of the treatment and prevention among this group of pregnant women.

Key words: Epstein–Barr virus infection, pregnancy, fetus, obstetric and perinatal complications, treatment and preventive measures.

REFERENCES

1. Savchenko TN, Aleshkin VA, Agaeva MI i dr. 2015. Beremennost i infektsiya, vyizvannaya virusom Epshteyna–Barr. Zdorove zhenschinyi 1:17–21.

2. Bodnar VA. 2013. Udoskonalennia diahnostyky khronichnykh form infektsii, zumovlenoi virusom Epshteina–Barr. Problemy ekolohii i medytsyny 17;5–6:9–15.

3. Kotlova VB, Kokoreva SP, Aralova EV i dr. 2013. Epshteyna-Barr virusnaya infektsiya v perinatologii. Zdorove i obrazovanie v HHI veke 15;8:1–7.

4. Zavidniuk NH. 2015. Aktualni problemy diahnostyky Epshteina-Barr virusnoi infektsii. Infektsiini khvoroby 4(82):79–86.

5. Lezhenko HO, Usachova OV, Silina YeA ta in. 2013. Infektsiinyi mononukleoz u ditei: kliniko-imunolohichna kharakterystyka. Aktualnaia ynfektolohyia 1(1):56–60.

6. Kazmirchuk VE, Maltsev DV. 2011. Diagnostika i lechenie infektsii, vyizvannoy Epshteyna-Barr virusom (virusom gerpesa cheloveka 4-go tipa). KlInIchna ImunologIya. AlergologIya. InfektologIya 4(43):69–75.

7. Duda OK, Kolesnyk RO, Okruzhnov MV ta in. 2015. Klinichni formy khronichnoi Epshteina–Barr virusnoi infektsii: pytannia suchasnoi diahnostyky ta likuvannia. Aktualnaia ynfektolohyia 1(6):35–40.

8. Kramarev SA, Vyigovskaya OV. 2013. Epshteyna–Barr virusnaya infektsiya u detey. Aktualnaya infektologiya 1(1):73–78.

9. Pokrovska TV. 2014. Khronichna Epshteina–Barr virusna infektsiia – aktualni pytannia. Infektsiini khvoroby 2:70–74.

10. Oludare А. 2011. Progress and problems in understanding and managing primary Epstein-Barr virus infection. Clin. Microb. Rev. 24;1:193–209.